Plausibility of therapeutic effects of Rho kinase inhibitors against Severe Acute Respiratory Syndrome Coronavirus 2 (COVID-19)

Pharmacol Res. 2020 Jun:156:104808. doi: 10.1016/j.phrs.2020.104808. Epub 2020 Apr 10.
No abstract available

Publication types

  • Letter

MeSH terms

  • Betacoronavirus*
  • COVID-19
  • COVID-19 Drug Treatment
  • Coronavirus Infections / drug therapy*
  • Humans
  • Pandemics
  • Pneumonia, Viral / drug therapy*
  • Protein Kinase Inhibitors / therapeutic use*
  • SARS-CoV-2
  • Signal Transduction / drug effects
  • rho-Associated Kinases / antagonists & inhibitors*

Substances

  • Protein Kinase Inhibitors
  • rho-Associated Kinases